Frontiers of therapy for hepatocellular carcinoma

Michael Heller; Neehar D Parikh; Nicholas Fidelman; Dawn Owen

doi:10.1007/s00261-021-03065-0

Frontiers of therapy for hepatocellular carcinoma

Abdom Radiol (NY). 2021 Aug;46(8):3648-3659. doi: 10.1007/s00261-021-03065-0. Epub 2021 Apr 10.

Authors

Michael Heller¹, Neehar D Parikh², Nicholas Fidelman³, Dawn Owen⁴

Affiliations

¹ Department of Interventional Radiology, University of California San Francisco, 505 Parnassus Avenue, M-361, San Francisco, CA, 94143, USA. Michael.Heller@UCSF.edu.
² Department of Medicine, University of Michigan, Ann Arbor, MI, USA.
³ Department of Interventional Radiology, University of California San Francisco, 505 Parnassus Avenue, M-361, San Francisco, CA, 94143, USA.
⁴ Department of Radiation Oncology, Mayo Clinic Rochester, Rochester, MN, USA.

PMID: 33837453
DOI: 10.1007/s00261-021-03065-0

Abstract

The incidence of hepatocellular carcinoma continues to increase worldwide. Fortunately, there have been notable recent advances in locoregional and systemic therapy. In this current review, we will highlight these new developments and future directions of hepatocellular carcinoma treatment and address the importance of a multidisciplinary approach to treatment.

Keywords: Hepatocellular Carcinoma; Oncology; Radiation therapy; Systemic therapy; Transarterial radioembolization.

Publication types

Research Support, Non-U.S. Gov't
Review

MeSH terms

Carcinoma, Hepatocellular* / diagnostic imaging
Carcinoma, Hepatocellular* / therapy
Chemoembolization, Therapeutic*
Humans
Liver Neoplasms* / diagnostic imaging
Liver Neoplasms* / therapy